don't get me wrong, i wont be selling until i get a fair price for my decade wait.
But i really expected a slow creep to $2 before the boom of efficacy.
we hit $2 in feb last year, and since then we have had more patients, IPO in the US and are 2 months away from apparent efficacy, yet we are at a 2 year low.
It amazes me.
Im putting it down to market instability.
Add to My Watchlist
What is My Watchlist?